THEMISMEDNSEThemis Medicare Limited· PharmaceuticalsMediumNeutral
Announced Fri, 27 Mar · 19:38 IST

Vividh Margi Investments Pvt ltd has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Promoter Stake BuyOwnership Changes View source PDF

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.3%1-day move
₹70.45
prior close
₹69.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-0.4-0.4-0.6+4.3+12.7+15.0+13.1+15.1+18.8+36.8+38.8+52.6+56.8
Up moveDown movePending
AI summary

Two promoter group entities of Themis Medicare — Vividh Distributors Pvt Ltd and Themis Distributors Pvt Ltd — have been amalgamated into Vividhmargi Investments Pvt Ltd (VMIPL) under a scheme approved by the Central Government on February 23, 2026, with the effective date being March 24, 2026. As a result, VMIPL's shareholding in Themis Medicare increased from 1,45,28,420 shares (15.77%) to 2,44,29,460 shares (26.52%), while VDPL and TDPL now hold zero shares. The total promoter group shareholding in the company remains unchanged — it is just consolidated into a single entity. The transaction is exempt from an open offer under Regulation 10(1)(d)(iii) of SEBI (SAST) Regulations, 2011, which covers inter se transfers between promoter group entities.

Likely market impact

This is a purely internal promoter group restructuring with no change in ultimate control or total promoter shareholding. No new external share acquisition took place, so the impact on retail shareholders is neutral and the stock price is unlikely to be materially affected.